Cytokines : as useful Prognostic Markers in Lymphoma Cases

Area of Science:

• Oncology
• Immunology
• Hematology

Background:

• Cytokines, including IL-2R and IL-6, are implicated in lymphoma pathogenesis.
• Enhanced cytokine expression is observed in patients with Hodgkin's and Non-Hodgkin's lymphoma.

Purpose of the Study:

• To investigate the role of IL-2R and IL-6 in lymphoma.
• To evaluate IL-2R and IL-6 as prognostic markers for lymphoma patients.

Main Methods:

• A multicentric study analyzed 72 lymphoma cases (45 Hodgkin's, 27 Non-Hodgkin's).
• Diagnosis was confirmed via tissue biopsies and fine needle aspiration cytology (FNAC).
• IL-2R and IL-6 levels were measured and compared to healthy controls, and changes post-chemotherapy were assessed.

Main Results:

• Both IL-2R and IL-6 levels were significantly increased (over fourfold) in lymphoma patients compared to controls.
• Cytokine levels generally decreased after chemotherapy in patients responding to treatment.
• Conflicting trends were observed with IL-6, where elevated levels sometimes persisted in clinical remission.

Conclusions:

• IL-2R and IL-6 serve as valuable indicators for assessing prognosis and drug therapy effectiveness in lymphoma.
• IL-2R demonstrates superior prognostic value compared to IL-6 in predicting chemotherapy response, particularly in Hodgkin's disease.